Algo version: 0.98b
CanSino Biologics Inc. is listed at the SHH Exchange
CanSino Biologics Inc. [688185.SS]
SHH Sector: Healthcare Industry:Drug Manufacturers—Specialty & Generic

Is CanSino Biologics Inc. stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, CanSino Biologics Inc. pays dividends. Last time was Tuesday 23rd of August 2022 where the investors holding the stock on Tuesday 23rd of August 2022 were paid CNY0.8 per share. Over the last 1 times between 2022 and 2022, CanSino Biologics Inc. has paid CNY0.8 with an average of CNY0.8 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for CanSino Biologics Inc. 10 years ago, but if you had invested on Thursday 13th of August 2020 when the price was CNY393.11, you would have made a loss of CNY-354.00 per share or -90.05%

Yes, the average daily trading liquidity for CanSino Biologics Inc. is CNY1.36 million. You should therefore be able to get in and out of your positions relatively fast.

CanSino Biologics Inc. has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for CanSino Biologics Inc. to be high [0.85 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.